English 
Spanish 
TWiV 959 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 3 December 2022 pdf […]
TWiV 959 Clinical Update Read More »
TWiV 957 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 26 November 2022 pdf
TWiV 957 Clinical Update Read More »
TWiV 955 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 19 November 2022 pdf
TWiV 955 Clinical Update Read More »
December 15, 2022
Progress Toward Poliomyelitis Eradication ― Afghanistan | Moderna Received FDA Emergency Use Authorization For Their Omicron-Targeting Bivalent Covid-19 Booster Vaccine In Children | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons | Authorized Updated (Bivalent) COVID-19 Vaccines for Children | Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster | Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir | The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions | Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
December 8, 2022
SARS-CoV-2 Serology and Self-Reported Infection Among Adults — National Health and Nutrition Examination Survey, United States, August 2021–May 2022 | Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes | Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
| Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants | Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022 | Triage of patients with Ebola virus disease
TWiV 953 Clinical Update
This Week in Virology Host: Vincent Racaniello Guest: Daniel Griffin Aired 12 November 2022 pdf
TWiV 953 Clinical Update Read More »
December 1, 2022
Is the risk of still and preterm birth affected by the timing of symptomatic SARS-CoV-2 infection during pregnancy? | Effectiveness of Influenza Vaccination of Pregnant Women for Prevention of Maternal and Early Infant Influenza-Associated Hospitalizations in South Africa | A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes | Single and 2-dose vaccinations with modified vaccinia Ankara-Bavarian Nordic® induce durable B cell memory responses comparable to replicating smallpox vaccines | Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals
November 24, 2022
Impact of community masking on COVID-19 | Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks | What is the place in therapy for nirmatrelvir/ritonavir? | Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
Parasites Without Borders at ASTMH 2022 Annual Meeting
Earlier this month, members of the Parasites Without Borders team traveled from New York, New Jersey, Florida, and Glasgow, Scotland to Seattle, Washington for the ASTMH 71st Annual Meeting at the Seattle Convention Center.
Parasites Without Borders at ASTMH 2022 Annual Meeting Read More »
November 16, 2022
Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection or Vaccination in Pregnancy | Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations | Acute and postacute sequelae associated with SARS-CoV-2 reinfection
